Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1→3)-β-d-glucan detection in serum samples as an adjunct to diagnosis
A case of invasive pulmonary aspergillosis caused by Aspergillus terreus is described. The diagnosis was based on demonstration of branched septate hyphae in a sputum specimen and isolation of the fungus in culture. The diagnosis was further supported by detection of A. terreus-specific DNA, galactomannan (GM) and (1→3)-β-d-glucan (BDG) in consecutive serum specimens. The patient was treated for about 10 weeks with voriconazole. The decreasing levels of GM and BDG in serum samples were accompanied by symptomatic and radiological improvement. The report highlights the value of surrogate markers in the diagnosis and for monitoring the course of invasive aspergillosis during therapy.
AhmadS.,
KhanZ. U.,
TheyyathelA. M.2007; Diagnostic value of DNA, (1–3)- β -d-glucan, and galactomannan detection in serum and bronchoalveolar lavage of mice experimentally infected with Aspergillus terreus
. Diagn Microbiol Infect Dis 59:165–171[CrossRef]
BaddleyJ. W.,
PappasP. G.,
SmithA. C.,
MoserS. A.2003; Epidemiology of Aspergillus terreus at a university hospital. J Clin Microbiol 41:5525–5529[CrossRef]
BlumG.,
PerkhoferS.,
GrifK.,
MayrA.,
KropshoferG.,
NachbaurD.,
Kafka-RitschR.,
DierichM. P.,
Lass-FlörlC.2008; A 1-year Aspergillus terreus surveillance study at the University Hospital of Innsbruck: molecular typing of environmental and clinical isolates. Clin Microbiol Infect 14:1146–1151[CrossRef]
GuineaJ.,
PeláezT.,
AlcaláL.,
BouzaE.2006; Outdoor environmental levels of Aspergillus spp. conidia over a wide geographical area. Med Mycol 44:349–356
HerbrechtR.,
DenningD. W.,
PattersonT. F.,
BennettJ. E.,
GreeneR. E.,
OestmannJ. W.,
KernW. V.,
MarrK. A.,
RibaudP.other authors2002; Voriconazole versus amphotericin B for primary therapy of invasive aspergillosis. N Engl J Med 347:408–415[CrossRef]
KedzierskaA.,
KochanP.,
PietrzykA.,
KedzierskaJ.2007; Current status of fungal cell wall components in the immunodiagnostics of invasive fungal infections in humans: galactomannan, mannan and (1→3)-beta-d-glucan antigens. Eur J Clin Microbiol Infect Dis 26:755–766[CrossRef]
KhanZ. U.,
AhmadS.,
MokaddasE.,
SaidT.,
NairM. P.,
HalimM. A.,
NampooryM. R.,
McGinnisM. R.2007; Cerebral aspergillosis diagnosed by detection of Aspergillus flavus -specific DNA, galactomannan and (1→3)- β -d-glucan in clinical specimens. J Med Microbiol 56:129–132[CrossRef]
KooS.,
BryarJ. M.,
BadenL. R.,
MartyF. M.2010; Prognostic features of galactomannan antigenemia in galactomannan-positive invasive aspergillosis. J Clin Microbiol 48:1255–1260[CrossRef]
Lass-FlörlC.,
KoflerG.,
KropshoferG.,
HermansJ.,
KreczyA.,
DierichM. P.,
NiederwieserD.1998; In vitro testing of susceptibility to amphotericin B is a reliable predictor of clinical outcome in invasive aspergillosis. J Antimicrob Chemother 42:497–502[CrossRef]
Lass-FlörlC.,
GriffK.,
MayrA.,
PetzerA.,
GastlG.,
BonattiH.,
FreundM.,
KropshoferG.,
DierichM. P.,
NachbaurD.2005; Epidemiology and outcome of infections due to Aspergillus terreus : 10-year single centre experience. Br J Haematol 131:201–207[CrossRef]
Lass-FlörlC.,
Alastruey-IzquierdoA.,
Cuenca-EstrellaM.,
PerkhoferS.,
Rodriguez-TudelaJ. L.2009; In vitro activities of various antifungal drugs against Aspergillus terreus : global assessment using the methodology of the European Committee on Antimicrobial Susceptibility Testing. Antimicrob Agents Chemother 53:794–795[CrossRef]
Mennink-KerstenM. A.,
RuegebrinkD.,
WaseiN.,
MelchersW. J.,
VerweijP. E.2006; In vitro release by Aspergillus fumigatus of galactofuranose antigens, 1,3-beta-d-glucan, and DNA, surrogate markers used for diagnosis of invasive aspergillosis. J Clin Microbiol 44:1711–1718[CrossRef]
ObayashiT.,
NegishiK.,
SuzukiT.,
FunataN.2008; Reappraisal of the serum (1→3)- β -d-glucan assay for the diagnosis of invasive fungal infections – a study based on autopsy cases from 6 years. Clin Infect Dis 46:1864–1870[CrossRef]
PazosC.,
PontónJ.,
Del PalacioA.2005; Contribution of (1→3)- β -d-glucan chromogenic assay to diagnosis and therapeutic monitoring of invasive aspergillosis in neutropenic adult patients: a comparison with serial screening for circulating galactomannan. J Clin Microbiol 43:299–305[CrossRef]
PickeringJ. W.,
SantH. W.,
BowlesC. A.,
RobertsW. L.,
WoodsG. L.2005; Evaluation of a (1→3)- β -d-glucan assay for diagnosis of invasive fungal infections. J Clin Microbiol 43:5957–5962[CrossRef]
SteinbachW. J.,
BenjaminD. K.Jr,
KontoyiannisD. P.,
PerfectJ. R.,
LutsarI.,
MarrK. A.,
LionakisM. S.,
TorresH. A.,
JafriH.other authors2004; Infections due to Aspergillus terreus : a multicenter retrospective analysis of 83 cases. Clin Infect Dis 39:192–198[CrossRef]
SuttonD. A.,
SancheS. E.,
RevankarS. G.,
FothergillA. W.,
RinaldiM. G.1999; In vitro amphotericin B resistance in clinical isolates of Aspergillus terreus , with a head-to-head comparison to voriconazole. J Clin Microbiol 37:2343–2345
VandewoudeK. H.,
BlotS. I.,
DepuydtP.,
BenoitD.,
TemmermanW.,
ColardynF.,
VogelaersD.2006; Clinical relevance of Aspergillus isolation from respiratory tract samples in critically ill patients. Crit Care 10:R31[CrossRef]
WalshT. J.,
AnaissieE. J.,
DenningD. W.,
HerbrechtR.,
KontoyiannisD. P.,
MarrK. A.,
MorrisonV. A.,
SegalB. H.,
SteinbachW. J.other authors2008; Treatment of aspergillosis: clinical practice guidelines of the Infectious Diseases Society of America. Clin Infect Dis 46:327–360[CrossRef]
Invasive pulmonary aspergillosis due to Aspergillus terreus: value of DNA, galactomannan and (1→3)-β-d-glucan detection in serum samples as an adjunct to diagnosis